Drug Profile
Allogeneic cultured keratinocytes and fibroblasts - Organogenesis
Alternative Names: Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen; GintuitLatest Information Update: 14 Dec 2018
Price :
$50
*
At a glance
- Originator Organogenesis
- Class Cell therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Gingival disorders
- Discontinued Alveolar bone loss
Most Recent Events
- 10 Dec 2018 As part of merger, Organogenesis became a subsidiary of Organogenesis Holdings (formerly Avista Healthcare Public)
- 10 Dec 2013 Organogenesis completes enrolment in its phase I/II trial for Gingival disorders & Alveolar bone loss following tooth extraction in the USA (NCT01929954)
- 31 Jul 2013 Phase-I/II clinical trials in Alveolar bone loss in USA (Topical)